Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$8.08 USD
-0.15 (-1.82%)
Updated Sep 17, 2025 03:59 PM ET
After-Market: $8.03 -0.05 (-0.62%) 7:58 PM ET
1-Strong Buy of 5 1
B Value A Growth C Momentum A VGM
Fundamental Charts
About Return on Equity (TTM)
Aveanna Healthcare Holdings Inc.'s return on equity, or ROE, is -54.56% compared to the ROE of the Medical - Outpatient and Home Healthcare industry of 8.78%. While this shows that AVAH has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
AVAH 8.08 -0.15(-1.82%)
Will AVAH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AVAH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVAH
Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
AVAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Buying the Best Top-Ranked Stocks in September
Should You Buy Aveanna Healthcare (AVAH) After Golden Cross?
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?
Other News for AVAH
Bain Capital Investors LLC Reduces Stake in Waystar Holding Corp
The technical outlook for AVAH is unchanged after it falls 1.91% on September 16
Bearish Engulfing appears for AVAH after 0.59% move
Deutsche Bank Keeps Their Buy Rating on Aveanna Healthcare Holdings (AVAH)
New 52 Week Closing High appears for AVAH after 0.24% move